ACCESS GPO

The purchasing power of a health system — without giving up your independence.

When device cost consumes ~50% of reimbursement, purchasing isn't operational — it's existential. ACCESS GPO gives independent EP ASCs the collective leverage to compete.

Apply to Join — Free →How It Works
For industry meetings & partner outreach
ACCESS GPO Partner Brochure
Two-page overview of the ACCESS platform, GPO value proposition, and partnership model.
View Brochure →
AFib ablation economics — the case for collective leverage
$7K–$13K
Device cost per case
Varies by ASC & structure
$15K–$20K
Reimbursement range
Market dependent
~50%
Device cost share
Of total reimbursement (J-8)
$0
Membership fee
Free to join ACCESS GPO
“When ~50% of reimbursement is device cost, purchasing isn't operational — it's existential.”
The EBITDA Math

Small per-case gains
compound fast.

At 300 EP cases per year, a $500 improvement per case is $150,000 of EBITDA. A $1,000 improvement is $300,000. These aren't projections — they're arithmetic. Purchasing leverage is the most direct lever available to independent ASCs in a fixed-reimbursement environment.

The margin reality
$18K reimbursement − $13K device cost = $5,000 remainingbefore anesthesia, staffing, overhead, capital, and risk. That's not margin. That's exposure.
Per-Case Improvement
Annual Cases
Annual EBITDA Impact
$250
300
$75,000
$500
300
$150,000
$750
300
$225,000
$1,000
300
$300,000
Strategic Focus

In a fixed-reimbursement world,
control what you can.

We don't control
✕CMS reimbursement rates
✕Payer fee schedule trends
✕Case complexity trajectory
✕Vendor consolidation pace
We control
✓Device purchasing economics
✓Capital structure & terms
✓Technology adoption timing
✓Operational efficiency
Standing alone in a 50% device-cost environment is a structural disadvantage.
Why Now

Physician-controlled aggregation
is no longer optional.

Hospitals aggregated first. Private equity aggregated next. Vendors consolidated globally. Yet many independent ASCs are still negotiating one by one. That's a mismatch in scale — and it's a structural disadvantage.

1
Hospitals
Aggregated first
2
Private Equity
Aggregated next
3
Vendors
Consolidated globally
4
Independent ASCs
Still negotiating individually
“Physician-controlled aggregation is no longer optional. It's defensive infrastructure.”
Technology Transitions

The transition
is happening
right now.

If you want access without damaging economics, you need leverage during the transition — not after. Early adopters shape referral networks.

PFA Catheter Systems
Active rollout
New capital + disposable economics being set now. Early allocation based on volume commitments. Patients are already asking.
Mapping Evolution
Next-gen adoption
Upgraded systems require capital renegotiation. Timing affects competitive position and referral network development.
Irrigated Catheter Redesigns
Iterating
Pricing and efficacy improvements continuing. Leverage determines access, cost, and which ASCs adopt first.
What Makes ACCESS Different

Not a buying club.
An economic coordination layer.

We negotiate around total economic structure — pricing, capital, roadmap, and data — not just disposable SKU cost.

Category
Typical GPO
ACCESS Model
Pricing focus
SKU discounts
Total economic structure
Incentive structure
Volume rebates
Capital + disposable alignment
Scope
Category-wide
EP-specific focus
Vendor relationship
Transactional
Technology roadmap influence
EP-Focused
Built around ASC EP economics, not hospital portfolios. Every contract decision is specific to the outpatient EP environment.
Voluntary
Clinical choice remains yours. No forced lock-in, no mandatory volume floors. Order what you need, when you need it.
Transparent
No officer compensation from vendor spreads. Zero conflicts of interest in pricing negotiations.
Compliant
Safe harbor structured. Administrative fees fully disclosed. No hidden markups, no undisclosed rebate flows.
Governance & Compliance

Scale with transparency
creates durability.

If a GPO cannot clearly articulate its compliance structure, that's not a small issue — that's governance weakness. ACCESS is built on explicit, auditable, physician-protective governance from day one.

“Scale without compliance creates risk. Scale with transparency creates durability.”
✓
Safe Harbor Compliance
Administrative fees structured under federal safe harbor provisions. Fully documented and auditable.
✓
No Officer Compensation from Vendor Spreads
Officers are not compensated from vendor spreads. Zero conflicts of interest in pricing negotiations.
✓
Full Fee Transparency
All administrative fees disclosed to members. No hidden markups, no undisclosed rebate flows.
✓
Voluntary Participation
No lock-in requirements. Clinical autonomy preserved. Physicians decide what works for their practice.
Live Contract

Medtronic PFA access —
already demonstrated.

ACCESS GPO has already demonstrated physician-led negotiating power through a successful Medtronic PFA access arrangement for independent ASCs. This is not a concept — it's a live contract.

Current vendor partner
Medtronic
Contract type
PFA access arrangement
Membership fee
$0 — Free to join
Volume commitments
None required
Additional vendors
In negotiation
Join ACCESS GPO

Start saving on day one.
No fees. No commitments.

Membership in ACCESS GPO is free for any physician-owned or physician-led EP ASC. Apply and get immediate access to the Medtronic contract and all future vendor agreements as they're added.

Apply Now — Free →Ask a Question
Membership fee
$0
Free to join
Volume commitments
None
Order what you need
Contract access
Immediate
Upon approval
Active vendor partner
Medtronic
More being added
Governance model
Physician-led
Safe harbor compliant